Lyell Immunopharma Stock Forecast

Stock Price Forecast

According to 2 professional analysts, the 12-month price target for Lyell Immunopharma stock ranges from a low of $10 to a high of $20. The average analyst price target of $15 forecasts a 42.18% increase in the stock price over the next year.

Price Target: $15.00 (+42.18%)

Analyst Consensus: Sell

Target	Low	Average	Median	High
Price	$10	$15	$20	$20
Change	-5.21%	+42.18%	+89.57%	+89.57%

* Price targets were last updated on Jun 24, 2025.

Analyst Ratings

The average analyst rating for Lyell Immunopharma stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $1 → $10	Hold	Maintains	$1 → $10	-5.21%	Jun 24, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $20	Hold	Reiterates	$20	+89.57%	Apr 16, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $20	Hold	Reiterates	$20	+89.57%	Mar 13, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $20	Hold	Reiterates	$20	+89.57%	Nov 12, 2024
Geoff Meacham B of A Securities	B of A Securities	Strong Buy → Sell Downgrades $120 → $20	Strong Buy → Sell	Downgrades	$120 → $20	+89.57%	Oct 30, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

8.67K

from 61.00K

-85.79%

from 61.00K

Revenue Next Year

n/a

from 8.67K

EPS This Year

-15.77

from -26.23

EPS Next Year

-14.85

from -15.77

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	7.76M	10.65M	84.68M	130.00K	61.00K	8.67K	-	31.11K
Revenue Growth	1,080.52%	37.31%	695.15%	-99.85%	-53.08%	-85.79%	-	-
EPS	-313.85	-36.82	-14.82	-18.70	-26.23	-15.77	-14.85	-6.77
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	10,500	n/a	64,050
Avg	8,670	n/a	31,110
Low	6,860	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-82.8%	-	-
Avg	-85.8%	-	-
Low	-88.8%	-	-

EPS Forecast

EPS	2025	2026	2027
High	-15.39	-13.49	-6.97
Avg	-15.77	-14.85	-6.77
Low	-15.93	-15.24	-6.51

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.